Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
Atazanavir for HIV Infected Individuals: An Early Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
- Status
- TERMINATED
- Phase
- PHASE2